Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2015 07:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at Two Investor Conferences in May

SAN DIEGO, April 28, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
March 16, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides Corporate Update and 2014 Year-End Financial Results

SAN DIEGO, March 16, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial...
March 09, 2015 08:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Corporate Update and Fourth Quarter and Year-End 2014 Financial Results Conference Call

SAN DIEGO, March 9, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the...
March 04, 2015 16:05 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 27th Annual Roth Conference

SAN DIEGO, March 4, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
February 11, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces $11 Million Registered Direct Offering With Sarissa Capital Management LP

SAN DIEGO, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it...
February 03, 2015 16:05 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Expands Exclusive License Agreement With an Existing Partner to Market Vitaros(R) in Select Asia-Pacific Countries

SAN DIEGO, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has...
February 03, 2015 08:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 17th Annual BIO CEO & Investor Conference

SAN DIEGO, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
January 27, 2015 16:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Issuance of U.S. Patent for RayVa(TM)

SAN DIEGO, Jan. 27, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, announced that today,...
January 12, 2015 07:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces the Appointment of Catherine Bovenizer as Vice President of Finance, Chief Accounting Officer

SAN DIEGO, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the...
January 06, 2015 07:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at Biotech Showcase 2015

SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced Richard...